{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-107580","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2024-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.559111+00:00","generated_at":"2026-05-31T03:59:53.085964+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Galecto regains Nasdaq minimum bid price compliance; matter closed","bullets":["Received Nasdaq Staff letter confirming compliance with Rule 5550(a)(2) based on bid price >= $1.00 from Aug 30 to Sep 13, 2024.","The deficiency notice is now closed; no further action required on this matter.","Shares continue trading on Nasdaq Capital Market under ticker GLTO."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-107580","json":"https://secwatch.observer/filing/0000950170-24-107580.json","markdown":"https://secwatch.observer/filing/0000950170-24-107580.md","text":"https://secwatch.observer/filing/0000950170-24-107580.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024107580/0000950170-24-107580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024107580/glto-20240916.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:59:53.085964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}